Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized interferon plus ribavirin treatment in treatment-naive chronic hepatitis C
ChiCTR-TRC-10001090Phase 4Completed
- Sponsor
- Third Hospital of Hebei Medical University
- Start
- Jan 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hepatitis C virus infection comparing Pegasys + ribavirin with Interferon alfa-2b + ribavirin (2 arms). Primary endpoint: Sustained virological response. Started Jan 2010; status: completed.
02
Drugs
interferon alfainterferon alfa-2bribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ChiCTR-TRC-10001090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001090.